Glass revealed that researchers were able to establish the long-term survival of Neuralstem's transplanted spinal cord stem cells in autopsied patients, through a technology called DNA fingerprinting.
http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Neuralstem-Investigator-Presents-New-ALS-NSI-566-D/ArticleNewsFeed/Article/detail/799320?ref=25
http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/Neuralstem-Investigator-Presents-New-ALS-NSI-566-D/ArticleNewsFeed/Article/detail/799320?ref=25
No comments:
Post a Comment